1. Home
  2. GEL vs TARS Comparison

GEL vs TARS Comparison

Compare GEL & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEL
  • TARS
  • Stock Information
  • Founded
  • GEL 1996
  • TARS 2016
  • Country
  • GEL United States
  • TARS United States
  • Employees
  • GEL N/A
  • TARS N/A
  • Industry
  • GEL Oil Refining/Marketing
  • TARS Medicinal Chemicals and Botanical Products
  • Sector
  • GEL Energy
  • TARS Health Care
  • Exchange
  • GEL Nasdaq
  • TARS Nasdaq
  • Market Cap
  • GEL 2.1B
  • TARS 1.7B
  • IPO Year
  • GEL 1996
  • TARS 2020
  • Fundamental
  • Price
  • GEL $16.80
  • TARS $54.03
  • Analyst Decision
  • GEL Buy
  • TARS Strong Buy
  • Analyst Count
  • GEL 3
  • TARS 7
  • Target Price
  • GEL $19.50
  • TARS $67.14
  • AVG Volume (30 Days)
  • GEL 457.6K
  • TARS 689.7K
  • Earning Date
  • GEL 10-30-2025
  • TARS 11-12-2025
  • Dividend Yield
  • GEL 4.03%
  • TARS N/A
  • EPS Growth
  • GEL N/A
  • TARS N/A
  • EPS
  • GEL N/A
  • TARS N/A
  • Revenue
  • GEL $2,877,249,000.00
  • TARS $295,521,000.00
  • Revenue This Year
  • GEL N/A
  • TARS $137.28
  • Revenue Next Year
  • GEL $19.09
  • TARS $42.84
  • P/E Ratio
  • GEL N/A
  • TARS N/A
  • Revenue Growth
  • GEL 17.61
  • TARS 254.45
  • 52 Week Low
  • GEL $9.86
  • TARS $31.05
  • 52 Week High
  • GEL $17.77
  • TARS $59.76
  • Technical
  • Relative Strength Index (RSI)
  • GEL 52.44
  • TARS 53.98
  • Support Level
  • GEL $15.86
  • TARS $48.20
  • Resistance Level
  • GEL $16.65
  • TARS $59.76
  • Average True Range (ATR)
  • GEL 0.44
  • TARS 2.17
  • MACD
  • GEL -0.02
  • TARS -0.99
  • Stochastic Oscillator
  • GEL 62.67
  • TARS 50.39

About GEL Genesis Energy L.P. Common Units

Genesis Energy LP is a limited partnership company that focuses on the midstream segment of the crude oil and natural gas industry. It engages in providing services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are offshore pipeline transportation, sodium minerals, and sulfur services, onshore facilities and transportation, and marine transportation. It generates maximum revenue from the offshore pipeline transportation segment which conducts crude oil and natural gas pipeline transportation and handling operations in the Gulf of Mexico through its offshore pipeline transportation segment, which focuses on providing a suite of services to integrated and large independent energy companies.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

Share on Social Networks: